Eleonora Shaubi

Title: Eleonora Shaubi: Innovator in Dopamine-Responsive Disorders Treatment

Introduction

Eleonora Shaubi is a notable inventor based in Beersheba, Israel. She has made significant contributions to the field of medical science, particularly in the treatment of dopamine-responsive disorders. Her innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Shaubi holds a patent for "L-DOPA and/or DOPA decarboxylase inhibitors conjugated to sugar for the treatment of dopamine-responsive disorders." This invention provides conjugates that include a sugar, such as mannitol, and one or more L-DOPA and/or DOPA decarboxylase inhibitors, including L-DOPA, carbidopa, and benserazide. The sugar is conjugated to the carboxyl group of the L-DOPA and/or DOPA decarboxylase inhibitors via a hydroxyl group of the sugar. This innovative approach offers related pharmaceutical compositions and methods for producing the conjugates, as well as methods for treating medical disorders responsive to dopaminergic stimulation, such as movement disorders including Parkinson's Disease.

Career Highlights

Throughout her career, Eleonora Shaubi has worked with the Ben-Gurion University of the Negev Research and Development Authority. Her work in this esteemed institution has allowed her to further her research and contribute to advancements in medical treatments.

Collaborations

Some of her notable coworkers include Eliahu Heldman and Moshe Kushnir. Their collaboration has likely enriched her research and development efforts in the field.

Conclusion

Eleonora Shaubi's innovative contributions to the treatment of dopamine-responsive disorders highlight her role as a significant inventor in the medical field. Her patent demonstrates a promising approach to addressing critical health challenges.